Literature DB >> 12704101

Brucella abortus RB51 induces protection in mice orally infected with the virulent strain B. abortus 2308.

Paolo Pasquali1, Adone Rosanna, Claudia Pistoia, Paola Petrucci, Franco Ciuchini.   

Abstract

Brucellae are gram-negative, facultative intracellular bacteria which are one of the most common causes of abortion in animals. In addition, they are the source of a severe zoonosis. In this trial, we evaluated the effect of oral inoculation of Brucella abortus RB51 in mice against a challenge infection with B. abortus 2308. First, we showed that a gastric acid neutralization prior to the oral inoculation contributed to a more homogeneous and consistent infection with both vaccine strain B. abortus RB51 and virulent strain B. abortus 2308. Successively, we assessed the clearance and the immune response following an oral infection with B. abortus RB51. Oral inoculation gave a mild infection which was cleared 42 days after infection, and it induced a delayed humoral and cell-mediated immune response. Finally, we immunized mice by oral inoculation with B. abortus RB51, and we challenged them with the virulent strain B. abortus 2308 by an oral or intraperitoneal route 42 days after vaccination. Oral inoculation of B. abortus RB51 was able to give protection to mice infected with the virulent strain B. abortus 2308 by the oral route but not to mice infected intraperitoneally. Our results indicate that oral inoculation of mice with B. abortus RB51 is able to give a protective immunity against an oral infection with virulent strains, and this protection seems to rely on an immune response at the mucosal level.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12704101      PMCID: PMC153221          DOI: 10.1128/IAI.71.5.2326-2330.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  20 in total

1.  Effect of exogenous interleukin-18 (IL-18) and IL-12 in the course of Brucella abortus 2308 infection in mice.

Authors:  Paolo Pasquali; Rosanna Adone; Louis C Gasbarre; Claudia Pistoia; Franco Ciuchini
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

2.  Responses of cattle to two dosages of Brucella abortus strain RB51: serology, clearance and efficacy.

Authors:  S C Olsen; B Bricker; M V Palmer; A E Jensen; N F Cheville
Journal:  Res Vet Sci       Date:  1999-04       Impact factor: 2.534

3.  Mouse cytokine profiles associated with Brucella abortus RB51 vaccination or B. abortus 2308 infection.

Authors:  P Pasquali; R Adone; L C Gasbarre; C Pistoia; F Ciuchini
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

4.  Immunization against Brucella infections: immune response of mice, guinea pigs, and Cynomolgus philipinensis to live and killed Brucella melitensis strain Rev. I administered by various methods.

Authors:  T H Chen; S S Elberg
Journal:  J Infect Dis       Date:  1970-12       Impact factor: 5.226

5.  Oral vaccination of sexually mature pigs with Brucella abortus vaccine strain RB51.

Authors:  M D Edmonds; L E Samartino; P G Hoyt; S D Hagius; J V Walker; F M Enright; G G Schurig; P Elzer
Journal:  Am J Vet Res       Date:  2001-08       Impact factor: 1.156

6.  Temporal development of protective cell-mediated and humoral immunity in BALB/c mice infected with Brucella abortus.

Authors:  L N Araya; P H Elzer; G E Rowe; F M Enright; A J Winter
Journal:  J Immunol       Date:  1989-11-15       Impact factor: 5.422

7.  Brucella abortus strain RB51 as a vector for heterologous protein expression and induction of specific Th1 type immune responses.

Authors:  R Vemulapalli; Y He; S M Boyle; N Sriranganathan; G G Schurig
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

8.  Endogenous gamma interferon mediates resistance to Brucella abortus infection.

Authors:  Y Zhan; C Cheers
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

9.  Biological properties of RB51; a stable rough strain of Brucella abortus.

Authors:  G G Schurig; R M Roop; T Bagchi; S Boyle; D Buhrman; N Sriranganathan
Journal:  Vet Microbiol       Date:  1991-07       Impact factor: 3.293

10.  Protection against infection and abortion induced by virulent challenge exposure after oral vaccination of cattle with Brucella abortus strain RB51.

Authors:  P H Elzer; F M Enright; L Colby; S D Hagius; J V Walker; M B Fatemi; J D Kopec; V C Beal; G G Schurig
Journal:  Am J Vet Res       Date:  1998-12       Impact factor: 1.156

View more
  19 in total

1.  Mouse model of oral infection with virulent type A Francisella tularensis.

Authors:  R KuoLee; X Zhao; J Austin; G Harris; J W Conlan; W Chen
Journal:  Infect Immun       Date:  2007-01-22       Impact factor: 3.441

2.  Protective live oral brucellosis vaccines stimulate Th1 and th17 cell responses.

Authors:  Beata Clapp; Jerod A Skyberg; Xinghong Yang; Theresa Thornburg; Nancy Walters; David W Pascual
Journal:  Infect Immun       Date:  2011-07-18       Impact factor: 3.441

Review 3.  Alternative strategies for vaccination to brucellosis.

Authors:  David W Pascual; Xinghong Yang; Hongbin Wang; Zakia Goodwin; Carol Hoffman; Beata Clapp
Journal:  Microbes Infect       Date:  2017-12-26       Impact factor: 2.700

4.  Protective properties of rifampin-resistant rough mutants of Brucella melitensis.

Authors:  R Adone; F Ciuchini; C Marianelli; M Tarantino; C Pistoia; G Marcon; P Petrucci; M Francia; G Riccardi; P Pasquali
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

5.  Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.

Authors:  Karina A Pasquevich; Silvia M Estein; Clara García Samartino; Clara García Samartino; Astrid Zwerdling; Lorena M Coria; Paula Barrionuevo; Carlos A Fossati; Guillermo H Giambartolomei; Juliana Cassataro
Journal:  Infect Immun       Date:  2008-11-03       Impact factor: 3.441

6.  Establishment of systemic Brucella melitensis infection through the digestive tract requires urease, the type IV secretion system, and lipopolysaccharide O antigen.

Authors:  Tatiane A Paixão; Christelle M Roux; Andreas B den Hartigh; Sumathi Sankaran-Walters; Satya Dandekar; Renato L Santos; Renée M Tsolis
Journal:  Infect Immun       Date:  2009-08-03       Impact factor: 3.441

7.  Targeting resident memory T cell immunity culminates in pulmonary and systemic protection against Brucella infection.

Authors:  Hongbin Wang; Carol Hoffman; Xinghong Yang; Beata Clapp; David W Pascual
Journal:  PLoS Pathog       Date:  2020-01-17       Impact factor: 6.823

8.  Oral vaccination with Brucella melitensis WR201 protects mice against intranasal challenge with virulent Brucella melitensis 16M.

Authors:  Mina J Izadjoo; Apurba K Bhattacharjee; Chrysanthi M Paranavitana; Ted L Hadfield; David L Hoover
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

Review 9.  What have we learned from brucellosis in the mouse model?

Authors:  María-Jesús Grilló; José María Blasco; Jean Pierre Gorvel; Ignacio Moriyón; Edgardo Moreno
Journal:  Vet Res       Date:  2012-04-13       Impact factor: 3.683

10.  Efficacy of strain RB51 vaccine in protecting infection and vertical transmission against Brucella abortus in Sprague-Dawley rats.

Authors:  Md Ariful Islam; Mst Minara Khatun; Byeong-Kirl Baek; Sung-Il Lee
Journal:  J Vet Sci       Date:  2009-09       Impact factor: 1.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.